Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports.
Lee S, Yang J, Jung S, Kim M, Yon D, Lee S, Kang H, Dragioti E, Tizaoui K, Jacob L, Koyanagi A, Salem J, Kostev K, Lascu A, Shin J, Kim J, Smith L. Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports. European Review For Medical And Pharmacological Sciences 2021, 25: 7390-7397. PMID: 34919240, DOI: 10.26355/eurrev_202112_27435.Peer-Reviewed Original ResearchConceptsAdverse reactionsIndividual case safety reportsReal-world settingsWorld Health Organization databaseCase safety reportsWHO global database of individual case safety reportsSafety reportsPharmacovigilance cohort studyNeural network methodAdverse drug reactionsAssociated with remdesivirBayesian neural network methodCohort studyPandemic outbreak of coronavirus disease 2019Clinical benefitWHO global databaseTreatment of COVID-19Remdesivir useDrug reactionsInformation componentNeuropsychological dysfunctionGS-5734Pharmacovigilance signalsCoronavirus disease 2019Outbreak of coronavirus disease 2019Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study
Kim M, Jung S, Lee S, Li H, Koyanagi A, Kronbichler A, Dragioti E, Tizaoui K, Wasuwanich P, Hong S, Ghayda R, Yoo H, Kim H, Jacob L, Salem J, Kostev K, Shin Y, Kim S, Gamerith G, Yon D, Shin J, Smith L. Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study. Clinical Gastroenterology And Hepatology 2021, 19: 1970-1972.e3. PMID: 33940227, DOI: 10.1016/j.cgh.2021.04.039.Peer-Reviewed Original ResearchConceptsRandomized placebo-controlled trialPlacebo-controlled trialGastrointestinal adverse drug reactionsInternational pharmacovigilance databaseAdverse drug reactionsGI-ADRsCOVID-19 patientsClinical benefitPharmacovigilance databaseIndividual case safety reportsDrug reactionsPharmacovigilance studiesCase safety reportsPatientsRemdesivirDiverse spectrumCoronavirus disease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply